AC
AUTL
Armistice Capital’s Autolus Therapeutics AUTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.4M | Buy |
12,000,000
+1,000,000
| +9% | +$2.28M | 0.47% | 27 |
|
|
2025
Q1 | $17.1M | Buy |
11,000,000
+1,800,000
| +20% | +$2.79M | 0.26% | 70 |
|
|
2024
Q4 | $21.6M | Buy |
9,200,000
+2,328,000
| +34% | +$5.47M | 0.3% | 63 |
|
|
2024
Q3 | $24.9M | Buy |
6,872,000
+622,000
| +10% | +$2.26M | 0.4% | 42 |
|
|
2024
Q2 | $21.8M | Buy |
6,250,000
+1,578,000
| +34% | +$5.49M | 0.27% | 59 |
|
|
2024
Q1 | $29.8M | Buy |
4,672,000
+822,000
| +21% | +$5.24M | 0.4% | 37 |
|
|
2023
Q4 | $24.8M | Sell |
3,850,000
-3,050,000
| -44% | -$19.6M | 0.34% | 50 |
|
|
2023
Q3 | $16.1M | Sell |
6,900,000
-364,000
| -5% | -$848K | 0.25% | 61 |
|
|
2023
Q2 | $17.3M | Sell |
7,264,000
-2,408,000
| -25% | -$5.73M | 0.25% | 72 |
|
|
2023
Q1 | $17.8M | Sell |
9,672,000
-552,000
| -5% | -$1.02M | 0.26% | 67 |
|
|
2022
Q4 | $19.4M | Buy |
+10,224,000
| New | +$19.4M | 0.34% | 55 |
|